drugset / Trial / NCT07303894
A Study of Isoquercetin in People With Ovarian Cancer
Phase 2
Recruiting
90 enrolled
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to test whether isoquercetin can reduce markers in the blood that may indicate the risk of blood clots in people with ovarian cancer. The effects of isoquercetin will be compared with those of a placebo.
Timeline
- Start
- 2026-01-22
- Primary completion
- 2032-01
- Completion
- 2032-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoquercetin | Small molecule | — | — |